Literature DB >> 53033

Lich myxedematosus. A dermal infiltrative disorder responsive to cyclophosphamide therapy.

S M Howsden, J H Herndon, R G Freeman.   

Abstract

Lichen myxedematosus is an uncommon, chronic, cutaneous disease of mucin deposition that has resisted a variety of therapies. The discovery of a unique, basic, homogeneous globulin in the sera of many of the patients with this disorder raised questions concerning the relationships between lichen myxedematosus, multiple myeloma, and amyloidosis. Our patient, who lacked the abnormal serum globulin, was successfully treated with cyclophosphamide.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53033     DOI: 10.1001/archderm.111.10.1325

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

2.  Cutaneous mucinosis associated with multiple frozen joints and bony heterotopic deposits around the hips.

Authors:  J P Dufour; J M Lachapelle; C Nagant de Deuxchaisnes; J P Devogelaer; H Noel; B Maldague
Journal:  Clin Rheumatol       Date:  1986-06       Impact factor: 2.980

3.  Widespread scleredema accompanied with a monoclonal gammopathy in a patient with advanced ankylosing spondylitis.

Authors:  Hyun Kyu Chang; You Chan Kim; Bum Sun Kwon
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

4.  Immunohistochemical investigations and introduction of new therapeutic strategies in scleromyxoedema: case report.

Authors:  Frank Breuckmann; Marcus Freitag; Sebastian Rotterdam; Markus Stuecker; Peter Altmeyer; Alexander Kreuter
Journal:  BMC Dermatol       Date:  2004-09-22

5.  Scleromyxedema: a case report and review of the literature.

Authors:  Mohamed Allam; Mohamed Ghozzi
Journal:  Case Rep Dermatol       Date:  2013-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.